STOCKHOLM, SE / ACCESS Newswire / April 1, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA ... that the company is participating at Redeye Theme: Alzheimer & Parkinsons on April 8, 10:55am, when CEO ...
Pharma brands that fail to evolve risk losing relevance in a world where patients demand more control, transparency, and personalized experiences. The Fast Company Executive Board is a private ...
STOCKHOLM, SE / ACCESS Newswire / April 1, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback